CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-05 | Roberts M Scot Chief Scientific Officer | Option exercise | +787 | $2.95 | $2K | 18,487 |
| 2022-07-05 | Roberts M Scot Chief Scientific Officer | Sale | −10,182 | $12.00 | $122K | 8,305 |
| 2022-07-05 | Roberts M Scot Chief Scientific Officer | Option exercise · Stock Options (option to buy) | −787 | 14,250 | ||
| 2022-07-01 | Roberts M Scot Chief Scientific Officer | Option exercise | +4,019 | $2.60 | $10K | 21,719 |
| 2022-07-01 | Roberts M Scot Chief Scientific Officer | Option exercise | +22,963 | $2.95 | $68K | 44,682 |
| 2022-07-01 | Roberts M Scot Chief Scientific Officer | Sale | −26,982 | $12.00 | $324K | 17,700 |
| 2022-07-01 | Roberts M Scot Chief Scientific Officer | Option exercise · Stock Options (option to buy) | −4,019 | 8,750 | ||
| 2022-07-01 | Roberts M Scot Chief Scientific Officer | Option exercise · Stock Options (option to buy) | −22,963 | 15,037 | ||
| 2022-06-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $11.70 | $35K | 277,811 |
| 2022-06-29 | Roberts M Scot Chief Scientific Officer | Option exercise | +5,462 | $2.60 | $14K | 23,162 |
| 2022-06-29 | Roberts M Scot Chief Scientific Officer | Sale | −5,462 | $12.00 | $66K | 17,700 |
| 2022-06-29 | Roberts M Scot Chief Scientific Officer | Option exercise · Stock Options (option to buy) | −5,462 | 12,769 | ||
| 2022-06-27 | Roberts M Scot Chief Scientific Officer | Option exercise | +25,583 | $1.92 | $49K | 43,283 |
| 2022-06-27 | Roberts M Scot Chief Scientific Officer | Option exercise | +11,769 | $2.60 | $31K | 55,052 |
| 2022-06-27 | Roberts M Scot Chief Scientific Officer | Sale | −37,352 | $12.00 | $448K | 17,700 |
| 2022-06-27 | Roberts M Scot Chief Scientific Officer | Option exercise · Stock Options (option to buy) | −25,583 | 35,817 | ||
| 2022-06-27 | Roberts M Scot Chief Scientific Officer | Option exercise · Stock Options (option to buy) | −11,769 | 18,231 | ||
| 2022-06-27 | Jorkasky Diane Director | Option exercise | +17,610 | $3.15 | $55K | 17,610 |
| 2022-06-27 | Jorkasky Diane Director | Sale | −17,610 | $11.75 | $207K | 0 |
| 2022-06-27 | Jorkasky Diane Director | Option exercise · Stock Options (option to buy) | −17,610 | 22,390 |
Page 16 of 29 · 568 trades